Mesenchymal stem cell therapy in pulmonary fibrosis: a meta-analysis of preclinical studies

BACKGROUND: Pulmonary fibrosis (PF) is a devastating disease characterized by remodeling of lung architecture and abnormal deposition of fibroblasts in parenchymal tissue and ultimately results in respiratory failure and death. Preclinical studies suggest that mesenchymal stem cell (MSC) administrat...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Deng-Yuan, Li, Ru-Fang, Sun, Dan-Xiong, Pu, Dan-Dan, Zhang, Yun-Hui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8371890/
https://www.ncbi.nlm.nih.gov/pubmed/34407861
http://dx.doi.org/10.1186/s13287-021-02496-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8371890/
https://www.ncbi.nlm.nih.gov/pubmed/34407861
http://dx.doi.org/10.1186/s13287-021-02496-2

Ejemplares similares